Viewing Study NCT02321592


Ignite Creation Date: 2025-12-24 @ 3:40 PM
Ignite Modification Date: 2025-12-25 @ 1:50 PM
Study NCT ID: NCT02321592
Status: COMPLETED
Last Update Posted: 2020-11-13
First Post: 2014-12-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: GHSG-AFM13 An Open-label, Multicenter Phase II Trial With AFM13 in Patients With Relapsed or Refractory Hodgkin Lymphoma
Sponsor: University of Cologne
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module